RE:RE:Feline patent action for BOEHRINGER INGELHEIM ANIMAL HEALTH You would think with the Allergan "MEGA" deal, pending clinical trial for their Botox killer (according to HV), pending deal for in the feline diabetes realm, new application of their SGLT2, management reorg, + SBM having to post their financials in a couple weeks which should disclose the upfront payment so big it made Howard smile that the shareprice would be ramping up in price and volume.
Instead..... anemic volume and a few pennies away from 52 week low. I put most if not all the reason behind this lack of enthusiasm regarding Sirona and thier prospects at the feet of their fearless CEO Howard V. Years of over promising and not delivering + lack of general communication have eroded any faith in this play. It has become the show-me stock cause unless they acutally show the details of the deal or a signed contract the market isn't pricing anything into this play. They simply don't believe Howard can execute based on past performance - for good reason - cause he hasn't executed. He has fumbled his way along for so many years the only reason they have signed any contracts is because of their technology in spite of the CEO's learn as you go methodology.